As the important active ingredients of Astragali Radix (AR), Astragalus polysaccharides
(APs) have therapeutic potential for multiple diseases including nervous system diseases …

Naturally occurring carbohydrate polymers containing non-starch polysaccharides (NPs) are
a class of biomacromolecules isolated from plants, marine algae, and edible mushrooms …

Despite advances in sequencing, lack of standardization makes comparisons across studies
challenging and hampers insights into the structure and function of microbial communities …

The emerging evidence supports the use of prebiotics like herb-derived polysaccharides for
treating nonalcoholic fatty liver disease (NAFLD) by modulating gut microbiome. The present …

Hepatic lipid accumulation, inflammation and gut microbiota dysbiosis are hallmarks of non-
alcoholic fatty liver disease (NAFLD), which is the leading cause of chronic liver disease with …

The increasing prevalence of metabolic diseases has become a severe public health
problem. Gut microbiota play important roles in maintaining human health by modulating the …

Hyperuricemia (HUA) is one of the most common chronic diseases today, with a prevalence
exceeding 14% in both the United States and China. Current clinical treatments for HUA …

Astragalus, a medical and edible plant in China, shows several bioactive properties.
However, the role of astragalus in attenuating alcoholic liver disease (ALD) is less clear. The …

The immunomodulatory effect of Astragalus polysaccharides (APS) has been revealed in
aquatic animals. However, the fundamental mechanisms in grass carp (Ctenopharyngodon …

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease in clinical practice. It
has been considered that NASH is one of the main causes of chronic liver disease, cirrhosis …